Vaxart to Speak at World Vaccine Congress Washington 2024 on April 3

Vaxart, Inc., a South San Francisco, California-based clinical-stage biotechnology company, is thrilled to announce that its Founder and Chief Scientific Officer, Dr. Sean Tucker, will be presenting at the World Vaccine Congress Washington 2024 in Washington, D.C. on April 3, 2024.

The presentation will focus on “Moving the needle: Blocking transmission and boosting existing vaccines by oral tablet vaccination”. This marks a recurring appearance for the company at the annual event in Washington, D.C. During his speech, Dr. Tucker will discuss how Vaxart’s proprietary delivery platform can revolutionize vaccine delivery by allowing for easy storage and shipping without refrigeration while also eliminating the risk of needle-stick injuries.

Vaxart is committed to developing oral recombinant vaccines using its proprietary delivery platform that are designed to be administered via pills. These vaccines have several advantages over traditional injectable vaccines as they eliminate the need for cold chain management and can be stored at room temperature or warmed up to body temperature before administration. Additionally, they can be easily transported and shipped without refrigeration, making them ideal for use in resource-limited settings such as developing countries where access to cold chain infrastructure may be limited or non-existent.

Currently, Vaxart’s development programs include pill vaccines for protection against coronavirus, norovirus, influenza and HPV (human papillomavirus), which is its first immune-oncology indication. The company has filed various patent applications domestically and internationally to cover its proprietary technology related to oral vaccination using adenovirus and TLR3 agonists.

For media relations inquiries please contact Mark Herr at Vaxart Inc., while investors should reach out to Andrew Blazier for more information about this exciting opportunity in vaccine development.

In summary, Vaxart Inc.’s Founder and Chief Scientific Officer Dr Sean Tucker will present at World Vaccine Congress Washington 2024 on April 3rd discussing how their proprietary delivery platform can revolutionize vaccine delivery by allowing easy storage and shipping without refrigeration while eliminating needle-stick injury risks. Their current development programs include pill vaccines for protection against several infectious diseases including COVID19 while filing various patents related to oral vaccination technology using adenovirus and TLR3 agonists respectively.

By Sophia Gonzalez

As a content writer at newsgreg.com, I am dedicated to crafting engaging stories that captivate our readers. With a knack for turning complex topics into accessible and compelling narratives, I weave words together to inform and inspire. My passion lies in delivering accurate and thought-provoking content that keeps our audience informed and entertained. From breaking news stories to in-depth features, I strive to bring a fresh perspective to every piece I create. Join me on this journey of exploration and discovery through the power of words at newsgreg.com.

Leave a Reply